Seeking Alpha

Bristol, Prime Medicine in deal to develop T-cell therapies

Prime Medicine (NASDAQ:PRME) and Bristol Myers Squibb (NYSE:BMY) will work together on the development of next-generation ex vivo T-cell therapies. The deal calls for Prime Medicine to design ...
Baylor College of Medicine

Bristol Myers Squibb Foundation, Texas Children’s Global HOPE, & Baylor College of Medicine Global Health launch program to combat sickle cell disease in Sub-Saharan Africa

Texas Children’s Global HOPE and Baylor College of Medicine Global Health, with support from the Bristol Myers Squibb Foundation, an independent charitable organization, announced the next front in ...
Benzinga.com

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline

Prime Medicine received $110 million upfront and is eligible for over $3.5 billion in milestone payments. Clinical trial data for PM359, targeting CGD, is expected in 2025, with other programs ...
University of Bristol

MRes Health Sciences Research

This programme offers a firm foundation in biomedical research, enhancing your understanding and critical awareness of the scientific method and practical experience in an area related to your ...
Seeking Alpha

Prime Medicine stock rallies 15% on Bristol Myers deal, drug updates

Prime Medicine (NASDAQ:PRME) shares rallied 15% Monday after the company announced a collaboration with Bristol Myers Squibb (NYSE:BMY), which includes a $55M equity investment. Under the deal, Prime ...
University of Bristol

Bristol researcher saving the humble cup of tea

Climate change is threatening tea plantations. A PhD student at the University of Bristol is fighting back using tea leaves picked from the hills of Sri Lanka 200 years ago. These leaves could save ...